During the past decade, Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Biocompatibles UK Ltd" with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin" are "Colorectal Cancer" (1 trials), "Gastric Cancer" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials) and "Rectal Cancer" (1 trials). Many other conditions were trialed in "Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin" in a lesser frequency.

Most popular intervention types in "Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin" are "Drug" (4 trials), "Device" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "5-Fluorouracil" (1 trials), "Capecitabine" (1 trials), "Cetuximab" (1 trials), "Chlorambucil" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".